CONFLICT OF INTEREST
EDWARDS
Anders Granholm, Marie Warrer Munch, Morten Hylander Møller and Anders Perner are affiliated with the Department of Intensive Care at Rigshospitalet—Copenhagen University Hospital, which has received funding for other projects from the Novo Nordisk Foundation, Sygeforsikringen ‘danmark’, Pfizer and Fresenius Kabi, and conducts contract research for AM‐Pharma. Vivekanand Jha has received grant funding from GSK, Baxter Healthcare and Biocon and has received honoraria from Bayer, AstraZeneca, Boeringer Ingelheim, NephroPlus and Zydus Cadilla, under the policy of all honoraria being paid to the organisation. Stephan M. Jakob reports that the Department of Intensive Care Medicine, University Hospital Bern, has or has had in the past, research and development/consulting contracts with Edwards Lifesciences Services GmbH, Phagenesis Limited, Nestlé and Cytel Inc. The money was paid into a departmental fund, Dr Jakob did not receive any financial gain. The Department of Intensive Care Medicine, University Hospital Bern has received in the past unrestricted educational grants from the following organisations for organising bi‐annual postgraduate courses in the fields of critical care ultrasound, management of ECMO and mechanical ventilation: Pierre Fabre Pharma AG (formerly known as RobaPharm), Pfizer AG, Bard Medica S.A., Abbott AG, Anandic Medical Systems, PanGas AG Healthcare, Orion Pharma, Bracco, Edwards Lifesciences AG, Hamilton Medical AG, Fresenius Kabi (Schweiz) AG, Getinge Group Maquet AG, Dräger Schweiz AG and Teleflex Medical GmbH.